Filing status
- Accounts due
- 18 April 2027
- Conf. stmt due
- 31 July 2027
- Last conf. stmt
- 17 July 2026
Sojourn Therapeutics Limited
- Incorporated
- 18 July 2025 (1 year)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Samuel Cohen
- Owned by
- Samuel CohenTuomas Pertti Jonathan Knowles
- Region
- Greater London
- Address
- 167-169 Great Portland Street5th FloorLondonW1W 5PF
Officers
This list may be incomplete. See all officers on Companies House
Officer details are public data from the Companies House register.
Cohen, Samuel
Director · Appointed 18 July 2025
British
Born October 1986 (40)
Director · Appointed 18 July 2025
British
Born June 1979 (47)
Director · Appointed 18 July 2025
American
Born March 1959 (67)
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Samuel Cohen
Individual · Notified 18 July 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born October 1986 (40)
Individual · Notified 18 July 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born June 1979 (47)
American
Born March 1959 (67)
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 August 2026 | Confirmation statement with updates | 17 July 2026 |
Other companies at this postcode
Over 1,000 have been registered at this postcode.
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →